US29604W1080 - ADR
ERYTECH PHARMA - SPON ADR
NASDAQ:ERYP (6/28/2023, 8:00:02 PM)
0.78
0 (0%)
ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 49 full-time employees. The company went IPO on 2013-05-07. The firm offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The firm's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death.
ERYTECH PHARMA - SPON ADR
60 avenue Rockefeller, Batiment Adenine
Lyon AUVERGNE-RHONE-ALPES 69008
P: 33478744438.0
CEO: Gil Beyen
Employees: 49
Website: https://erytech.com/
It's time for another dive into the biggest pre-market stock movers traders need to know about as we cover the winners and losers for Friday!
It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Thursday!
Lexaria Bioscience (LEXX) stock is falling on Tuesday after the company revealed details about its public share offering.
Ohmyhome (OMH) stock is taking a beating on Tuesday but it's not due to any recent news concerning the property management company.
Palantir (PLTR) stock is on the rise Tuesday morning after the company posted earnings for the first quarter of the year!
Erytech Pharma (ERYP) stock is on the rise Tuesday after the company provided investors with a business update for the first quarter of 2023!
Here you can normally see the latest stock twits on ERYP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: